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Abstract.  A  monoclonal antibody raised against mi- 
totic spindles isolated from CHO cells ([CHO1], Sel- 
litto,  C.,  and R. Kuriyama.  1988.  J.  Cell Biol. 
106:431-439) identifies an epitope that resides on 
polypeptides of 95 and  105 kD and is localized in the 
spindles of diverse organisms.  The antigen is dis- 
tributed throughout the spindle at metaphase but be- 
comes concentrated in a progressively narrower zone 
on either side of the spindle midplane as anaphase 
progresses.  Microinjection of CHO1, either as an as- 
cites fluid or as purified IgM,  results in mitotic inhibi- 
tion in a  stage-specific and dose-dependent manner. 
Parallel control injections with nonimmune IgMs do 
not yield significant mitotic inhibition.  Immunofluores- 
cence analysis of injected cells reveals that those 
which complete mitosis display normal localization of 
CHO1, whereas arrested cells show no specific local- 
ization of the CHOI antigen within the spindle.  Immu- 
noelectron microscopic images of such arrested cells 
indicate aberrant microtubule organization.  The CHO1 
antigen  in HeLa cell extracts copurifies with taxol- 
stabilized microtubules.  Neither of the polypeptides 
bearing the antigen is extracted from microtubules by 
ATP or GTP, but both are ,,060 % extracted with 
0.5 M  NaCI.  Sucrose gradient analysis reveals that the 
antigens  sediment at •llS.  The CHO 1 antigen ap- 
pears to be a  novel mitotic MAP whose proper distri- 
bution within the spindle is required for mitosis.  The 
properties of the antigen(s)  suggest that the corre- 
sponding protein(s) are part of the mechanism that 
holds the antiparaUel  microtubules of the two inter- 
digitating  half spindles together during anaphase. 
T 
HE mitotic  spindle  is  the  structure  responsible  for 
the equipartition of chromosomes during mitosis.  Al- 
though there are numerous descriptions of the mitotic 
events visible at the microscopic level, we know little about 
the molecular aspects of spindle function.  The inherent com- 
plexity of the spindle, combined with its extreme lability, has 
made  such  analyses  difficult.  Efforts  to identify  spindle- 
specific molecules from a variety of cell types have demon- 
strated the complexity of the spindle,  but have thus far told 
us little about the molecules essential  for mitosis.  To go be- 
yond descriptive biochemistry one needs a functional  assay 
whereby to gauge the importance of a given molecule for mi- 
totic progression. 
There are at present two methods to determine the role of 
a given protein during  mitosis.  One powerful approach in- 
volves the creation of mutations that alter the gene(s) encod- 
ing a protein of interest.  Although this method allows one to 
examine the function  of a protein with precision, the requi- 
site mutant  cells must be found,  and  the list of mitosis- 
blocking mutations is not very long at present (reviewed in 
Mclntosh and Koonce, 1989).  An alternative  approach in- 
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volves the microinjection  of antibodies against putative mi- 
totic proteins into dividing cells. The microinjection method 
is advantageous because the antigen(s) recognized by the an- 
tibody need not be well characterized at the initiation  of the 
experiments.  Furthermore, the effects of the antibodies can 
be monitored in real time. Microinjection has been used suc- 
cessfully to probe the mitotic functions of MAP 4 (Izant et 
al., 1983), calcium transport enzymes (Silver, 1986; Hafner 
and Petzelt,  1987),  a 62-kD phosphoprotein in mitotic sea 
urchin spindles (Dinsmore and Sloboda,  1989) and the mam- 
malian homologue of yeast CDC 2 (Riawol et al., 1989). In 
each case this method has provided useful information about 
the possible roles of the corresponding antigens during mito- 
sis. In this paper we have used microinjection to probe the 
role in mitosis of an interesting but thus far poorly character- 
ized  antigen.  Sellitto  and  Kuriyama  (1988)  described an 
mAb, CHO1, that was raised against spindles  isolated from 
CHO ceils. The antigen recognized by this antibody appears 
to be a component of interphase  nuclei and centrosomes as 
well as the mitotic matrix that binds to interzonal  microtu- 
bules during anaphase.  It is confined to the region where in- 
terdigitating microtubules overlap near the spindle midplane. 
To obtain evidence about the mitotic functions of the CHO1 
antigen we have microinjected CHO1 ascites fluid or purified 
CliO1 IgM into PtKt cells at various times in mitosis. These 
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specific manner, suggesting that the CHO1 antigen is impor- 
tant for normal mitotic progression.  Biochemical analyses 
have  indicated that the polypeptides  recognized by CHO1 
bind to microtubules in vitro in a nucleotide insensitive, salt 
sensitive manner.  Collectively,  these data  suggest that the 
CHO1  antigen(s)  are novel mitotic microtubule-associated 
proteins (MAPs) t required  for mitosis in PtK1 cells. 
Materials and Methods 
General Materials 
Unless otherwise specified, all reagents were from Sigma Chemical Co. (St. 
Louis, MO). Taxol was the generous gift of Dr. Matthew Suffness (National 
Cancer Institute). 
Preparation and Purification of  Antibodies 
An ascites fluid containing the CHO1  IgM (Sellitto and Kuriyama, 1988) 
was  precipitated by  the  addition of 50%  ammonium  sulfate  (pH  7.4), 
resuspended in half its original volume of PBS (136 mM NaCI,  80 mM 
Na2HPO,  3 mM KC1, 2  mM MgCI2,  and  1 mM KPO4) dialysed against 
PBS or injection buffer (140 mM K +, 100 mM glutamic acid, 40 mM citric 
acid 1 mM MgC12, and 1 mM EGTA at pH Z4), and either purified further 
or concentrated, using a microconcentrator (Centricon 30; Amicon, Dan- 
vers, MA) to one-tenth the original volume. Further purification was per- 
formed by loading 0.5 ml of ammonium sulfate-precipitated antibody onto 
a 21-ml (1.5  x  27 cm) Sephacryl S-300 gel filtration column (Pharmacia 
Fine Chemicals, Piscataway,  NJ) and eluting with PBS at room temperature 
(Jehanli and Hough,  1981).  0.5-ml fractions were collected and analyzed 
electrophoretically followed by immunoblotting (Towbin et ai., 1979) with 
goat antibodies to the # chain of mouse IgM (Bio-Rad Laboratories, Rich- 
mond, VA) to locate the proteins of interest. Commercial mouse IgM (Cal- 
biochem-Behring Corp., La Jolla, CA) was used on these blots as a stan- 
dard. IgM- and non-IgM-containing fractions were pooled separately and 
concentrated with a Centricon 30 for subsequent mieroinjection. For some 
experiments the IgM was precipitated with 40% ammonium sulfate, chro- 
matographed as before, then further purified by passage over a 700-/~1 pro- 
tein G column (Pierce Chemical Co., Rockford, IL) that had been equili- 
brated with sodium phosphate buffer (145 mM NaCI, 7.5 mM NaH2PO4, 
and 2.5 mM NaI-IPO4 at pH 7.2). The flow through from this column which 
contained purified CHO1 IgM was coilected and concentrated to •10  mg/ 
ml as described above. In other experiments the ascites fluid from a mouse 
injected with a nonimmune, IgM-secreting hybridoma (gift of Bonnie Neigh- 
bors, University of Colorado) was processed and purified as above to serve 
as microinjection controls. 
Microinjection 
Antibody solutions were dialyzed against two changes of 300 vol of injec- 
tion buffer (see above) then clarified by centrifugation for 30 rain in a 
microfuge, and stored at 4°C until used. In most cases, FITC-conjugated 
dextran was added to the antibody solutions at a concentration of 1 mg/ml 
before dialysis. Microinjections were performed according to Saxton and 
Mclntosh (t987). Based on earlier calculations (Zavortink et al., 1983) we 
estimate injections to be ~10 % of the cell's volume. The protein concentra- 
tions of the injectates, as loaded into the needles, ranged from 1-50 mg/ml. 
Cells to be microinjected were subcultured in Ham's F-12 medium sup- 
plemented with  10%  FCS  (Gibco Laboratories,  Grand Island,  NY)  on 
etched glass coverslips (Bellco, Vineland, NJ). These coverslips facilitated 
subsequent identification of  injected cells and their progeny. Coverslips con- 
taining ceils at '~70% confluence were tacked down to 35-mm petri dishes 
with  valap  (vaseline,  lanolin,  and  paraffin at  1:1:1) then  covered with 
medium. Selected mitotic cells were mieroinjected with glass micropipettes 
made on a  Brown-Flaming P-77  pipette puller (Sutter Instruments, San 
Francisco, CA) from capillaries of 1.0 mm o.d. and containing an internal 
1. Abbreviations used in this paper: MAP, microtubule-associated protein; 
PHEM, 60/~M Pipes, 25/~M Hepes, 10 mM EGTA, and 2 mM MgSO4; 
PMEG, 100 mM Pipes, 5 mM MgSO,,,  5 mM EGTA, 0.5 mM EDTA, 0.9 
M glycerol, pH 6.9. 
filament to aid loading the needles (World Precision Instruments, New Ha- 
ven, CT). Cells were injected at room temperature while being observed 
with a  phase-contrast, water immersion objective (40x,  n.a.  0.75;  Carl 
Zeiss; Oberkochen, FRG). For most experiments between 30 and 40 cells 
per coverslip were injected over the course of 20 min. 
After a series of injections, the coverslip was scanned and any injected 
cells that appeared to be injured were discounted from further analysis.  Cells 
were placed in fresh medium in a 60-ram petri dish and placed in a 37"C 
incubator for 3 h. After this recovery period, injected cells were examined 
to determine their mitotic stage. Cells that had divided successfully were 
identified as pairs of fluorescent cells, whereas cells that had failed to divide 
were seen as individual fluorescent cells. These arrested cells were exam- 
ined microscopically  to determine the stage at which they had arrested. The 
microinjection experiments were performed under double-blind conditions. 
For each series of injections, two antibody solutions were prepared, a con- 
trol IgM and CHO1 IgM. (The commercially prepared mouse IgM used as 
a  control did not stain any mitotic structures in our immunofluorescent 
preparations.) Aliquots of these samples were then coded so that the in- 
dividual performing the injections and subsequently scoring the cells did 
not know the identity of the samples. 
Immunofluorescence Microscopy 
Both PtKl and HeLa ceils were grown to ,~70% confluence on 12-ram cir- 
cular coverslips as described above, then fixed directly in cold methanol, 
as described by Neighbors et ai. (1988),  or lysed for 1 min in PMEG buffer 
(100 mM Pipes, 5 mM MgSO4,  5 mM EGTA, 0.5 mM EDTA, and 0.9 M 
glycerol at pH 6.9) containing 1.0% Triton X-100  and  1 #M taxol, then 
fixed. CHO1 ascites or purified CHO1 IgM was typically used as a primary 
antibody at a 1:500 dilution in PBS for 2 h followed by three washes in PBS 
and a 1 h incubation with a Texas Red-conjugated goat anti-mouse second- 
ary antibody (Fisher Scientific Co., Springfield, NJ) diluted 1:200 in PBS 
for  1 h.  For double label experiments, cells labelled as described were 
washed for 40 rain in PBS, then incubated for 2 h with a mouse monoclonal 
antitubulin (Scholey et al., 1984) followed by an FITC-conjagated goat anti- 
mouse secondary antibody (U.S. Biochemical Corp., Cleveland, OH) di- 
luted 1:100 in PBS for 1 h. Though this procedure used two primary anti- 
bodies from mouse, no cross-reactivity of  the second goat antibody with the 
first primary antibody was observed. Control experiments in which the an- 
titubulin incubation was omitted confirmed that the FITC-conjugated goat 
anti-mouse did not stain the CHO1/Texas Red-labeled cells. In some experi- 
ments DAPI (4',6-diarnidino-2-phenylindole  dihydrochloride) was added to 
the final PBS wash (at 1 #g/ml) to stain the chromosomes. Cells injected 
with either CHO1 or control antibodies were processed as above, except that 
the first antibody incubation step was omitted. Coverslips were mounted in 
Gelvatol (Monsanto, Indian Orchard, MA) with 5% n-propyl gallate and 
observed on a Zeiss universal microscope equipped with both phase and 
epi-fluorescence optics, using a  Zeiss phase contrast oil immersion lens 
(100×, n.a. 1.25). Images were recorded on T-Max 3200 film (Eastman Ko- 
dak Co., Rochester, NY) developed at 29°C according to the manufacturer's 
instructions. 
Immunoelectron Microscopy 
PtKl cells were grown as described above on glow discharged, Formvar 
and carbon-coated gold finder grids (Fullam, Latham, NY). Mitotic cells 
were injected with CHO1 IgM as described, lysed for 1 rain at room temp 
with 0.2% Triton X-100 in PHEM buffer (60 mM Pipes, 25 mM Hepes, 
10 mM EGTA, and 2 mM MgSO4) then fixed with 2.0% paraformaldebyde 
and 0.1% glutaraldehyde in PHEM for 20 rain at room temperature. Fixed 
cells were treated with 10 mg/ml sodium borohydride in 50% ethanol and 
50% PBS then returned to PBS. Fixed cells were incubated with antitubulin 
for 2 h at 37°C followed by goat anti-mouse antibodies conjugated to 15 
nm colloidal gold (Janssen Life Sciences, Olen, Belgium) for 3 h at room 
temperature.  Labeled cells were dehydrated in a  graded ethanol series, 
transferred to dry acetone, and then critical point dried from liquid CO2 in 
a  CPD 020 (Balz rs, Hudson, NH).  Dried specimens were viewed in a 
JEOL JEM-1000 electron microscope at  1 MeV. 
Preparation of CH01 Antigen from HeLa Cells 
HeLa cells were grown in suspension culture and harvested by centrifuga- 
tion and separated into nuclear and cytoplasmic fractions according to the 
method of Arias and Dynan (1989).  Briefly, cells were lysed in a hypotonic 
buffer (10 mM Tris-HCl, pH 7.9,  10 mM KCI, 1.5 mM MgC12 and 1 mM 
DTT) and centrifuged at 3000 rpm in a rotor (model JS 13.1; Beckman In- 
The Journal  of Cell Biology,  Volume l 11,  1990  512 Figure/.  Immunolocalization  of the CHO1 antigen at different stages of mitosis in PtK, cells. Cells were lysed and prepared  as described 
in Materials and Methods.  The same cell for each stage is seen in phase contrast (a-g), after staining with anti-tubulin  (a'-g') and CHO1 
(a"-g").  Bar, 5 #m in all micrographs. 
"Nislow et al. An Essential Mitotic MAP  513 struments, Palo Alto, CA) to separate nuclei and cytoplasm. Clarified cyto- 
plasmic extracts were prepared by centrifugation in PMEG buffer, pH 6.9 
containing soybean trypsin inhibitor,  aprotinin,  leupeptin,  pepstatin,  and 
benzamidine at 1/~g/rnl at 140000 g at 4*(2 for 45 rain. Nuclear fractions 
were prepared according to Arias and Dynan (1989) by extracting nuclei 
with 50 mM Tris-HC1, pH 7.5, 20% glycerol, 10% sucrose, 0.42 mM KCI, 
5 mM MgCI2, 0.I mM EDTA, and 2 mM DTT for 30 rain at 4°C then cen- 
trifuging at 21,000 rpm in a rotor (model SW27; Beckman Instnunents) for 
1.5 h at 4"C. Ammonium sulfate (33%) was then added to the supernatant 
from this spin. This mixture was stirred for 1 h at 4"C then centrifuged at 
15,000 rpm in a rotor (model SW27; Beckman Instruments) for 15 rain at 
4°C.  The resulting pellet was resuspended in 50 mM Tris-HCl,  pH 7.9, 
1 mM EDTA, 20% glycerol, 12.5 mM MgC12, and 0.1 M KC1 containing 
the same cocktail of protease inhibitors used for the cytoplasmic extract. 
The resulting nuclear extract was then clarified in a microfuge. Clarified cy- 
toplasmic and nuclear extracts were supplemented with 1 mM GTP and 10 
~M taxol, then incubated at 37"C for 5 rain,  followed by the addition of 
1 mg/ml taxol-stabilized  microtubulcs  (prepared  from phosphocellulose 
purified tubulin [W'dliams and Detrich,  1979]) and incubated at 37"C for 
an additional 40 rain. The micrombules and their associated proteins were 
pelleted through a 15% sucrose cushion for 1 h at 25,000 g at 30°C. The 
pellet of  microtubules plus associated proteins (MTP) was washed in PMEG 
containing 10 t~M taxol, then extracted simultaneously with 5 mM MgATP 
and 5 mM MgGTP (in PMEG containing 10 t~M taxol) for 30 rain at 25"C. 
After extraction, the pellet and supernatant fractions were separated by cen- 
trifugation at 40,000 g for 30 rain at 30"C. This pellet was then resnspended 
in PMEG plus taxol and extracted sequentially with 0.5 M NaCl then 1.0 
M NaC1 in PMEG containing  10 t~M taxol.  To control for proteins that 
might sediment nonspecifically with microtubules, clarified cytoplasmic ex- 
tracts were incubated and processed as above except both taxol and GTP 
were omitted and 0.1/~g/ml nocodazole was added to prevent the polymer- 
ization of micmtubules. 
Sucrose Density Gradient Centrifugation 
200-td samples of iligh speed supernatant prepared from HeLa cytoplasm 
were loaded onto 4.2 ml 5-20% sucrose gradients (pmimred  in PMEG), then 
centrifuged at 300,000 g for &5 h at 4"C in an SW60 rotor (Beckman Instru- 
ments). For each run, two gradients were loa_~eM_ with I mg/ml of  the follow- 
ing standards: cytochrome  c (2.IS), catalase (ILLS),  and tbyrnglobulin  09.283. 
Each gradient was collected into 14 fractions of 300 ~1 each, adjusted to 
1 mM GTP, 10 t~m taxol, and 1 mg/ml taxol-stabilized mierotubules. These 
fractions were incubated for 30 rain at room temperature, then centrifuged 
in an airfuge (Beckman Instruments) at 100,000 g for 15 rain at 22"C. Su- 
pernatants from these preparations were removed and the pellets were re- 
suspended in one-third the original volume of PMEG before analysis via 
SDS-PAGE and immunoblotting. 
Other Biochemical Procedures 
Whole  PtKI  cell  extracts  were  prepared  by rinsing  adherent  cells  with 
PMEG at 40C followed by removal of the cells by scraping with a rubber 
policeman. PtK1 cells were then rinsed twice in PMEG, re,  suspended in 2 
vol of PMEG containing the same cocktail of protease inhibitors used for 
HeLa cells, disrupted by sonication and boiled in gel sample buffer. 
Protein conceatrations were measured according to the method of Brad- 
ford (1976) using bovine IgG as a standard. SDS-PAGE was performed on 
7.5% acrylamide slab gels (0.75 mm thick) in a Mini Slab apparatus (Idea 
Scientific, Corvallis,  OR)  using a  modification of the buffer system of 
Laemmli (1970). The bis/acrylamide ratio was reduced to one-one hundredth 
to allow better transfer of proteins to nitrocellulose. Gels were stained with 
Coomassie blue and/or silver nitrate. For immunoblots, proteins were trans- 
ferred to 0.22-1zm nitrocellulose (Schleicher & Schuell, Inc., Keene, NH) 
according to Towbin et at.  (1979) for 1.75 h at 12 V in a Genie Mini Blot 
apparatus (Idea Scientific). Blots were probed sequentially with antibodies 
for 2 h each at 370C, then visualized via the immunopemxidase reaction 
(Bio-Rad Laboratories,  Richmond,  CA). 
Results 
Localization of CH01 in PtK Cells 
The mAb designated CHO1 recognizes an epitope within the 
mitotic spindle and midbody of CHO ceils (Sellitto and Kuri- 
yama,  1988).  This cell type is not convenient for microin- 
jection during mitosis because the cells are small, and they 
round up during prophase.  PtKI cells,  however, are larger 
and remain relatively flat during mitosis, making them suit- 
able for microinjection.  To determine the normal distribu- 
tion of CHO1 in mitotic PtK~ cells, we processed these cells 
for double-label immunofluorescence,  using CHO1  and an 
antitubulin mAb (Fig.  1). Both lysed and unlysed cells dis- 
played similar localization patterns, but the lysed prepara- 
tions afforded a dearer immtmofluorescent signal, so we will 
focus our descriptions  on them.  In prophase cells,  CHO1 
stains fibers and punctate spots within the nucleus, but there 
is no detectable cytoplasmic staining (Fig. 1, a-a"). By pro- 
metaphase a dim, speckled staining by CHO1 is visible along 
the spindle microtubules (Fig.  I, b-b").  This staining ap- 
pears more uniform and intense by metaphase (Fig. 1, c-c"). 
At the onset of anaphase, CHO1 staining becomes localized 
to a discrete band of fibers that run between the separating 
chromosomes (Fig.  1, d-d"). By late anaphase, staining in- 
tensity increases and is more sharply localized to the region 
near the middle of the spindle where interpolar microtubules 
interdigitate  (Fig.  1,  e-e").  During  telophase,  staining  is 
seen only within the cytoplasmic  bridge that separates the 
two daughter cells. At this stage CHO1 staining is brightest 
where inter'zonal micrombules remain interdigitated (Fig. 1, 
f-f"). By the completion of cytokinesis staining is confined 
to the midbody (Fig. 1, g-g"). From these images it appears 
that the CHO1  staining pattern is similar in both PtKI and 
CHO cells. 
Microinjection of CHO1 
We have examined the effect of microinjecting  CHO1  into 
mitotic PtK~ cells. Ascites fluid containing either CHO1 or 
a  nonimmune IgM  at various  concentrations  ranging  be- 
tween 1 and 50 mg/ml was injected into PtK~ cells at differ- 
ent stages of mitosis (all concentrations cited refer to the to- 
tal protein concentration of a given sample within the needle 
before~microinjection).  Micminjection of mitotic cells with 
~10% of their volume containing  12.5 mg/ml of CHO1 as- 
cites fluid led to mitotic arrest in a stage-specific  manner. 
When cells were injected during prophase, prometaphase or 
metaphase,  70-75%  became  arrested  in  a  metaphase-like 
configuration  (Table  I).  Higher  concentrations  of ascites 
fluid proteins  (up to 50 mg/ml)  had no greater  inhibitory 
Table I. The Effects of Microinjection  of an 
Ascites Fluid Containing CH01 and a Nonimmune 
Ascites Fluid into Mitotic PtK1 Cells 
Mitotic arrest (n=) 
Sample*  Before AO*  After AO§ 
CHO1  (12.5  mg/ml)  73(128)  22(85) 
CHOI  (8.0 mg/ml)  44(36)  ND 
CHO1  (5.5 mg/ml)  30(28)  ND 
CHO1  (4.0 mg/ml)  21(30)  ND 
Control  (12.5  mg/ml)  14(113)  13(50) 
* For each sample the protein concentration listed refers to the concentration 
within the needle before microinjection. 
* Before AO, cells were injected before the onset of anaphasc. 
§ After AO, ccUs were injected after the onset of anaphase. 
The loumal of Cell Biology, Volume 111, 1990  514 Figure 2.  Purification of the CHO1 IgM via gel filtration chroma- 
tography. Column fractions were electrophoresed  on a 7.5 % poly- 
acrylamide gel and stained with Coomassie blue (A) or blotted to 
nitrocellulose  and probed with goat anti-mouse IgM (B).  (MW) 
Molecular weight markers in kilodaltons.  (Load) Ammonium sul- 
fate precipitated  CHO1 ascites fluid that was loaded onto the col- 
umn.  (25-49)  Column fractions.  (IgM) Commercial mouse IgM. 
Fractions  25-31  (+) and 39-45  (-) were pooled,  concentrated, 
and denoted "IgM" and "non IgM," respectively. 
affect, but at lower concentrations (<8 mg/ml) mitotic inhi- 
bition was proportionally less (Table I). Significantly less in- 
hibition was also observed when cells were injected after the 
onset of anaphase (20-30%).  Injection of control ascites at 
12.5 mg/ml resulted in 10-15 % inhibition, regardless of the 
time of injection. 
To control for the possibility that CHOl-injected cells were 
simply delayed in completing mitosis, we observed several 
injected cells 6-7 h after injection. None of the arrested cells 
divided.  By  that  time  they  appeared  to  lose  viability,  as 
determined  by their  appearance in  the  phase contrast mi- 
croscope  and  their  permeability to  trypan blue  (data  not 
shown). 
To determine whether the mitotic inhibition observed in 
injected cells was really due to the action of CHO1 (as op- 
posed to an unidentified component of the ascites fluid) we 
used gel filtration chromatography to enrich the preparation 
for IgM.  SDS-PAGE  and  immunoblot analysis  of the  gel 
filtration column fractions with anti-mouse IgM antibodies 
revealed that these immunoglobulins eluted immediately af- 
ter the void volume with few contaminating proteins (com- 
pared with commercially purified mouse IgM) (Fig.  2). 
To determine if the chromatography had damaged the abil- 
ity of CHO1 to recognize its antigen,  we tested the avidity 
of this partially purified IgM relative to the original ascites 
by serially diluting both preparations (at comparable protein 
concentrations) until no signal was detected via indirect im- 
munofluorescence  of fixed  PtK1 cells.  Assuming  that  the 
IgM constftuted approximately half of the ascites fluid pro- 
teins (see Fig. 2), we estimate that the chromatographed IgM 
was ~75 % as avid as its counterpart in the original ascites 
fluid. 
Column  fractions containing  either  the  isolated IgM or 
non-IgM proteins were pooled separately, concentrated via 
ultrafiltration and dialysed as described in the Materials and 
Methods.  Microinjection of purified IgM into mitotic cells 
resulted in a pattern of stage-specific mitotic arrest similar 
to that obtained with whole ascites, although the inhibition 
was significant at lower protein concentrations  (compared 
with the whole ascites fluid) (Fig. 3). Injection of CHO1 IgM 
at  t>8  mg/ml  into  prophase,  prometaphase or  metaphase 
cells resulted in a  metaphase-like arrest in  80-85 % of the 
cases.  As  with the  ascites fluid,  injections  following ana- 
phase onset had little effect. Control injections with a purified 
nonimmune IgM monoclonal antibody at equivalent concen- 
trations led to 9-16 % arrest, regardless of the stage injected. 
The control cells that did not divide usually ceased mitotic 
progression in the stage at which they were injected, in con- 
trast to the metaphase-like block observed with CHO1 injec- 
tions. 
To determine the response of PtKI cells to different doses 
of purified CHO1, we injected a dilution series of the anti- 
body during prometaphase, then scored these cells for com- 
pletion of mitosis 3  h  later  (Fig.  4).  Inhibition of mitotic 
progression decreased from 85 % at 8 mg/ml to 24 % inhibi- 
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Figure 3. Effect of microinjection of CHO1 IgM or a control IgM 
on mitotic progression in PtKt cells. Cells were injected at differ- 
ent stages (Pro, prophase;  ProMeta, prometaphase;  Meta, meta- 
phase; AnaA, anaphase A; and AnaB, Anaphase B) with "~10% of 
their volume of IgM at 8 mg/ml (protein concentration in needle). 
Injected cells were observed  and scored 3 h after injection.  The 
number of cells injected at each stage is indicated  (n=). 
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Figure 4.  Dose response of mitotic PtK~ cells to microinjection of 
CHO1. Ceils were injected before the onset of anaphase with a dilu- 
tion series of CHO1 IgM (1-15 mg/ml), with non IgM at 8 mg/ml 
(see Fig. 2) or with injection buffer alone. The number of cells in- 
jected with each sample is indicated  (n=). 
tion at 1 mg/ml. For these experiments, two different control 
solutions were prepared. First we concentrated column frac- 
tions containing primarily non-IgM proteins to 8 mg/ml and 
injected  this  sample into  PtK1  cells during prometaphase. 
Approximately 20-23 %  of these  cells became arrested  at 
metaphase (Fig. 4). These numbers are strikingly similar to 
those obtained with injection of 1 mg/ml of CHO1 IgM and 
probably  reflect  a  contamination  of the  non-IgM  column 
fractions with a  small quantity of CHO1 IgM (see Fig.  2). 
To circumvent this contamination, we constructed a second 
control in which prometaphase cells were injected with com- 
mercially purified mouse IgM at 8 mg/ml. In these experi- 
ments only 8-10 % of the injected cells failed to complete mi- 
tosis (data not shown). 
As a third control, we attempted to remove all contaminat- 
ing  IgG and  further  purify  CHO1  IgM.  CHO1  does  not 
precipitate in low ionic strength buffers as described by Kie- 
hart et al.  (1986).  However, a second chromatographic step 
(as described in Materials and Methods)  resulted in nearly 
homogeneous IgM which was devoid of IgG (Fig. 5 a). This 
preparation  and  control  BSA  were  injected  into  mitotic 
PtK~ cells before anaphase onset using a  double blind ex- 
perimental design (Fig.  5  b).  The degrees of mitotic arrest 
achieved with this material was similar to that seen with the 
singly chromatographed CHO1  IgM (compare Figs.  5  and 
3). Based on these several controls we are confident that the 
metaphase-like arrest observed in cells injected with CHO1 
is due to the action of the antibody. 
To obtain a  more detailed view of the effect of microin- 
jected CHO1 on mitotic progression, injected cells were pro- 
cessed for indirect immunofluorescent staining to visualize 
either the injected antibody or the  spindle and its chromo- 
somes. Cells injected at prometaphase with 2 mg/ml CHO1 
IgM (a concentration that did not normally inhibit mitosis) 
Figure 5. Effect of  microinjection of  highly purified CHOI IgM into 
mitotic PtK~ cells. (A) Coomassie blue-stained gel of the purified 
CHO1 IgM.  Note that  the predominant  polypeptides  migrate at 
,o70 and ,o29 kD, corresponding to the IgM heavy and light chains, 
respectively. (B) Histogram showing the response of PtKl cells in- 
jected before anaphase  onset with 8 mg/ml of either  CHO1 IgM 
(dark bar)  or BSA (light bar).  Injected  cells were observed  and 
scored 3 h after injection.  The number of cells injected with each 
sample is indicated  (n=). 
were fixed at various times after injection and reacted with 
secondary antibody conjugated to Texas Red to localize the 
bound CHO1 (Fig. 6, a and b). In all cases the staining pat- 
tern of these injected cells was similar to that observed in 
uninjected cells stained directly with CHO1.  Cells injected 
during anaphase with 8 mg/ml of CHO1 IgM (another treat- 
ment that normally has no effect on mitotic progression) also 
showed the normal localization of CHO1  (Fig.  6  c).  These 
results demonstrate that CHO1 injected into the cytoplasm 
can recognize its native antigen in a  normal manner.  Both 
spindle  and chromosome morphology appeared normal in 
those ceils that were capable of dividing. 
Next we focused on cells that were injected before anaphase 
onset with 8  mg/ml of CHO1  IgM and became arrested at 
metaphase.  Cells  injected  before nuclear  envelope break- 
down proceeded to a metaphase-like state on schedule with 
control cells but did not develop further.  The chromosomes 
in these arrested cells remained condensed near the spindle 
equator (Fig. 6, d and e). Staining these cells with antitubu- 
Figure 6. Immunofluorescent  analysis of injected cells. The same cells are seen in phase contrast  (a-f), stained with fluorescein labeled 
anti-tubulin  (a'-f') or stained  with a Texas Red-labeled goat anti-mouse secondary antibody to visualize  injected IgMs (a"-f"'). Cells 
were lysed and fixed as in Fig.  1. Top (I) illustrates the effects of microinjection  of nonrestrictive  doses of CHO1 IgM. In all cases the 
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later. (b-b")  Cell injected as in a  but fixed 3 h later. (c-c")  Cell injected during anaphase A with 8 mg/ml CHO1  then fixed 3 h later. 
Bottom (H) illustrates the effects of restrictive doses of CHO1  IgM. (d-d")  Cell injected during prometaphase with 8 mg/ml CHO1  IgM 
then fixed 3 h later. This cell has become arrested at metaphase. (e-e") Cell injected as in d and fixed 3 h later. Note the formation of 
supernumerary asters (e'). (f-f") Cell injected during prometaphase with 8 mg/ml control mouse IgM and then fixed 3 h later. Note that 
the extent of delocalization  of CHO1 from the spindle varies widely from d" (extreme delocalization) to e" (moderate delocalization). Bar, 
5/zm in all micrographs. 
Nislow et al. An Essential Mitotic MAP  517 Figure 7. Whole mount immunoelectron microscopic analysis of a CHOl-arrested cell. Cells were prepared as described in Materials and 
Methods and stained with antitubulin and 10 nm colloidal gold-labeled secondary antibodies to enhance the contrast of the microtubules. 
(a) Low-magnification  view of a representative cell injected with 8 mg/ml CHO1 IgM during prometaphase and fixed 3 h later. Note the 
short, stubby appearance of the spindle and the lack of focused spindle poles in this cell. (a') Higher magnification view of the spindle 
pole of a. (b) Low-magnification  view of an uninjected metaphase cell that was on the same grid as the cell in a shown for comparison. 
(b') Higher magnification view of the pole in (b). Bar, 5 #m in all micrographs. 
lin antibodies  showed that their spindles  look reasonably 
normal at the light microscopic level, although 30--40% of 
these cells contain one to three additional spindle poles (Fig. 
6 e). Visualization of CHO1 in the same cells revealed that 
the injected antibody was diffusely distributed throughout 
the cytoplasm with spindle staining barely detectable above 
background, in either lysed (Fig. 6) or unlysed preparations 
(data not shown). This observation is distinct from the spin- 
dle staining seen in fixed, uninjected metaphase cells treated 
directly with CHO1 (compare with Fig.  1, b" and c"). The 
dispersal of CHO1 antigen in cells arrested by CHO1 injec- 
tion suggests that the mechanism of mitotic arrest may be 
related to the lack of  proper localization of  the CHO1 antigen 
in the spindle (see Discussion). 
Spindle morphology in injected cells was studied at higher 
resolution  by  whole-mount  immunoelectron  microscopy, 
using antitubulin and colloidal gold-labeled secondary anti- 
bodies. Seven cells that were injected with 8 mg/ml CHO1 
IgM  at  prometaphase and  became arrested  at  metaphase 
were examined ultrastructurally. The overall morphology of 
these cells resembled similarly treated cells observed with 
phase  microscopy, yet closer analysis  of the  microtubule 
structure of these cells revealed several features not detected 
in the immunofluorescent preparations. The cells examined 
appeared to have arrested before achieving a true metaphase 
configuration; often one or more chromosomes or chromo- 
some fragments were several micrometers from the spindle 
equator (Fig.  7 a, arrow). The microtubules in each half 
spindle were not organized into discrete spindle fibers, nor 
did they focus at the poles, as they do in uninjected cells at 
metaphase (Fig. 7 b). Instead these microtubules emanate 
diffusely from the polar region. Organized centrosomes were 
not readily discernible in these cells. The ultrastructural data 
suggest that the microtubule organization of injected cells 
compromised, particularly near the poles. 
Biochemical Characteristics of the CHOI Antigen 
The microinjection experiments suggest that the CHO1 anti- 
gen might be an important mitotic MAP. To investigate this 
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gen(s) in HeLa cells.  Samples were 
prepared  as  described  in  Materials 
and  Methods.  (A) Immunolocaliza- 
tion of the CHO1 antigen in mitotic 
HeLa cells. The same cell is seen in 
phase contrast (1 and 3) and stained 
with CHOI (2 and 4). Bar,  5/~m in 
all micrographs. (B) 7.5 % polyacryl- 
amide  gel  stained  with  Coomassie 
blue.  (C)  Corresponding  immuno- 
blot probed with CHOI IgM. Lanes 
correspond to: (1) molecular weight 
markers  (in  kilodaltons);  (2)  high- 
speed  supernatant  prepared  from 
HeLa cytoplasm; (3) supernatant af- 
ter  addition  and  centrifugation  of 
taxol microtubules; (4) pellet of taxol 
rnicrotubules and MAPs (MTP); (5) 
supernatant after extraction of MTP 
with 5 mM MgATP plus 5 mM Mg- 
GTP; (6) MTP pellet after MgATP 
and MgGTP extraction; (7) superna- 
tant  after  extraction  of MTP  with 
0.5  M  NaC1;  (8)  MTP pellet after 
0.5 M NaC1 extraction; (9) superna- 
tant  after  extraction  of MTP  with 
1.0 M  NaC1;  (10) MTP pellet after 
1.0  M  NaC1  extraction.  (11)  high- 
speed  supematant  prepared  from 
HeLa cell nuclei; (12) pellet of taxol 
microtubules  and  nuclear  MAPs; 
and (13) whole, sonicated PtK cells. 
Lanes 2, 3,//, and 13 represent equal 
loadings of samples of a similar pro- 
tein concentration.  Lanes 4-10 and 
12 represent a thirty-fold reduction in 
sample volume. 
possibility further we initiated a biochemical analysis of the 
protein(s)  recognized  by  CHO1.  It  has  been  shown  that 
CHO1 binds to polypeptides of •95  and ,'~105 kD on immu- 
noblots  of isolated  CHO  spindles  (Sellitto  and  Kuriyama, 
1988).  These  polypeptides  appeared  to  be  minor  compo- 
nents of these preparations, because corresponding gel bands 
could  not be identified  in Coomassie-stained  gels of these 
preparations.  As an alternative  approach  to characterizing 
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HeLa cell extracts. We separated HeLa cells into nuclear and 
cytoplasmic components (see Materials and Methods), pre- 
pared a high-speed supernatant (HSS) from the cytoplasmic 
fraction, and then prepared a crude microtubule plus MAPs 
(MTP) pellet by supplementing it with preformed, taxol- 
stabilized microtubules, followed by centrifugation. HeLa 
cells were chosen for this analysis because large quantities 
of these cells were available to us and the immunofluorescent 
staining pattern of CHO, PtK~, and HeLa cells is indistin- 
guishable (Fig. 8, a  and Sellitto and Kuriyama, 1988). 
Blots of  the HeLa fractions probed with purified CHO1 an- 
tibody revealed the presence of two polypeptides of molecu- 
lar weights similar to those described for CHO cells (,,o100 
and ~115 kD). Faint antibody staining on blots was detected 
in the HSS (Fig. 8 c, lane 2). The MTP fraction was greatly 
enriched for these antigens (over HSS), indicating that the 
CHO1 antigens bind to microtubules in vitro (Fig. 8 c, lane 
4). When the HSS was incubated with 0.1 #g/ml nocodazole 
to prevent microtubule assembly, the CHO1 antigens did not 
pellet in a comparable centfifugation (see Materials and Meth- 
ods, data not shown). To examine the microtubule binding 
characteristics of the cytoplasmic antigen we extracted the 
cytoplasmic taxol-stabilized MTP with 5 mM MgATP and 
5 mM MgGTP (Fig. 8, lanes 5 and 6) and then with two con- 
centrations of NaC1 (Fig. 8, lanes 7 and 8). Both polypep- 
tides remained associated with the microtubules after extrac- 
tion with nucleotides (Fig. 8, lanes 5 and 6), but 0.5 M NaCl 
removed between one-half and two-thirds of both polypep- 
tides from the microtubule pellet (Fig. 8, lanes 7and 8). Sub- 
sequent extractions with 1.0 M NaCI did not extract any more 
of the antigen from the microtubule fraction (Fig. 8, lanes 
9 and 10). These results indicate that the polypeptides recog- 
nized by CHO1 bind to exogenous bovine brain microtubules 
in an ATP/GTP insensitive, but partially salt-sensitive man- 
ner. The identification on Coomassie-stained gels of the poly- 
peptides responsible for the observed immunoreaction with 
CHO1 was hampered by the presence of numerous bands in 
the relevant region of the gel. 
We also asked whether the nuclear staining by CHO1, ob- 
served in immunofluorescentpreparations, was due to the 
same antigen as that recognized by CHO1 in the cytoplasm. 
HeLa nuclei and nuclear proteins,  prepared  according to 
Arias and Dynan (1989), were fractionated into nuclear HSS 
and MTP  as  above,  then analyzed on immunoblots with 
CHO1 (Fig. 8, lanes 11 and 12). The CHO1 antigen in inter- 
phase  nuclei  comprise  a  microtubule  binding  protein  of 
about the same R/as at that seen in the cytoplasm. This ob- 
servation corroborates the immunofluorescent images of in- 
terphase and prophase cells and further suggests that the nu- 
clear form of CHO1 antigen retains its microtubule binding 
properties. 
To control for the use of two different cell types in these 
experiments, PtK~ cells for microinjecfion and immunoflu- 
orescence and HeLa cells for the biochemical analysis, we 
probed an immunoblot of whole PtKI cells with CHO1 IgM. 
This experiment revealed the presence of  an immunoreactive 
band of,M00 kD and the absence of any other cross reacting 
polypeptides in PtK~ cells (Fig. 8, lane 13). 
The sedimentation velocity of the CHO1 cytoplasmic anti- 
gen from HeLa cells was determined for comparison with 
those of other known MAPs (reviewed in Olmstead, 1986). 
HeLa cell cytoplasmic HSS was fractionated on a 5-20 % su- 
crose gradient.  Each fraction from the gradient was sup- 
plemented with preformed microtubules, centrifuged, and 
the resulting pellets were analyzed electrophorefically. Im- 
munoblots of these fractions reveal that the CHO1 antigen(s) 
in HeLa cells sediment at l lS (data not shown). 
Discussion 
We have demonstrated that the epitope recognized by CHO1 
is associated with the spindle microtubules of PtKI cells in 
stage-specific patterns that resemble those observed previ- 
ously in CHO cells (Sellitto and Kuriyama, 1988). Microin- 
jection of sufficient quantifies of  CHO1 antibody into mitotic 
PtKz cells inhibits mitotic progression, supporting the idea 
that the CHO1  antigen is an essential mitotic protein. The 
exact mechanism whereby the antibody arrests mitosis is, 
however, unclear. Examination of injected and arrested cells 
reveals that CHO1 blocks mitotic progression just before full 
metaphase; one or two chromosomes are often some dis- 
tance from the spindle equator, suggesting that chromosome 
congression was partially impaired.  The spindle microtu- 
bules of injected cells were also disorganized, failing to bun- 
dle into discrete kinetochore fibers and to focus at the poles; 
rather they terminated some distance from the centrosome 
and formed broad poles and a "stubby" spindle. 
A  comparison of the morphology of cells injected with 
CHO1 IgM or control IgM suggests several interpretations 
of the effects of the antibody injections. First, the antibody 
might be  cross-linking  adjacent microtubules  within the 
spindle (directly or indirectly), effectively inhibiting further 
microtubule movements. We think this possibility unlikely, 
considering  that  cells  injected  during  prophase  proceed 
through  most  of prometaphase.  Second,  injected  CHO1 
might block the binding of the antigens to the spindle or re- 
move  them  from  the  spindle  during  prometaphase  and 
metaphase. Removal of these antigens from the spindle be- 
fore anaphase onset may prevent the establishment of a nor- 
mal  metaphase configuration, causing the  cells  to  arrest 
prior to this stage. Injection of CHO1 appears to delocalize 
the antigen from the spindle, resulting in a higher concentra- 
tion of antigen within the cytoplasm (Fig. 6, d and e). Be- 
cause the CHO1  antigen is localized in normal cells where 
it may serve to connect antiparallel spindle microtubules, the 
inactivation  of  the  antigen  by  antibody  injection  might 
destabilize the spindle microtubules. Also, the formation of 
a stable interzone, which normally occurs during anaphase, 
might be impaired in the injected cells. 
Considering the staining pattern of CHO1  in cells fixed 
during anaphase, we were surprised that injection of CHO1 
had little effect on mitotic progression once anaphase com- 
menced. From this we infer that once the CHO1 antigen has 
reached its target within the interzone during anaphase, it is 
protected from the perturbing effects of the antibody. This 
protection could arise if the association of CHO1 antigen 
with the interzonal microtubules and/or spindle matrix alters 
the antigen in such a  way to make it less susceptible to 
removal by the antibody. The lack of  an anaphase effect  might 
also reflect either steric hindrance of the antibody by the 
closely aligned microtubules within the interzone or an in- 
sufficient amount of time for the antibody to have an effect 
before the CHO1  antigen accomplishes its task. Further, it 
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its mitotic function by the onset of anaphase. 
An alternative mechanism whereby CHO1 might inhibit 
mitotic progression is suggested by the observation that cells 
arrested by antibody  injection persist in a  metaphase-like 
state for 6-7 h until they lose viability. This persistence is 
not observed in cells blocked with various microtubule poi- 
sons. Such drugged cells usually resume an interphase con- 
figuration  within 2-3  h  of treatment  (Zieve et al.,  1980). 
That  CHO1  arrested  cells remain  in mitosis  for extended 
periods may mean that the corresponding antigens play a role 
in cell cycle regulation. The localization of the CHO1 antigen 
is similar in some ways to the distribution of a few molecules 
known to be important for mitotic control, such as the anti- 
gens recognized by MPM-2 (Vandre et al., 1984) and the in- 
ner centromere (INCENP) antigens  (Cooke et al.,  1987). 
We have been puzzled by the high concentration of CHO1 
antibody required to inhibit mitotic progression.  There are 
several possible explanations  for the need of such a  large 
quantity  of antibody.  First,  there could be a large pool of 
CHO1 antigen in the cytoplasm.  This is unlikely given the 
low levels of background staining observed with CHO1 even 
in unlysed preparations.  Second, the avidity of the antibody 
might be low. Again this does not appear to be the case since 
CHO1 staining is detected on fixed cells at 1:5,000 dilution 
of the ascites fluid. Third, the CHO1 antigen might comprise 
an enzyme. Accordingly, it might be necessary to inactivate 
all of the antigen to block mitosis.  Fourth,  the PtK~ cyto- 
plasm might be degrading the injected antibody. While we 
have no direct evidence on the half-life of the injected anti- 
body, fluorescent IgGs injected into fibroblasts persist as dif- 
fuse fluorescence for several hours, suggesting that they re- 
main soluble and probably retain their ability to bind antigen 
(Stacey and Allfrey,  1977). Finally, the accessibility of the 
injected antibody to its antigen in the cytoplasm might be im- 
paired.  This  is plausible given the extreme density of the 
cytoplasm near the spindle. Indeed, Fuchtbauer et al. (1985) 
have shown that even high concentrations of high-affinity an- 
titubulin antibodies that cause disintegration of cytoplasmic 
microtubules do not affect spindle microtubules.  Addition- 
ally, these authors observed the disintegration of cytoplasmic 
microtubules in lysed cell models at concentrations signifi- 
cantly lower than those required for similar effects in vivo. 
This observation supports the idea that cytoplasm is deleteri- 
ous to the activity of some antibodies. 
The CHO1 antigen appears to be a MAP. This assertion 
is  based  on  the  observation  that  the  antigen  binds  to 
preformed,  taxol-stabilized  microtubules  in  vitro.  Unlike 
many other previously described MAPs (Olmsted, 1986) the 
CHO1 antigen(s) does not bind to all cytoplasmic microtu- 
bules, rather it appears to colocalize only with interdigitat- 
ing,  antiparallel  microtubules during mitosis.  Given its lo- 
calization,  its  molecular  weight,  its  microtubule  binding 
properties,  and its sedimentation velocity, we suppose that 
the CHO1 antigen(s) make up a novel MAP.  Several other 
proteins  do,  however,  display  similar  immunolocalization 
patterns  on  interzonal  microtubules  during  anaphase  and 
telophase. Among these are epitopes identified using partic- 
ular autoimmune sera, i.e., INCENPs (Cooke et al.,  1987); 
a 38-kD antigen (Kingwell et al.,  1987); a 200-kD antigen 
(Lyderson  and  Pettijohn,  1980);  the  tektins  (Steffen  and 
Linck,  1989);  mitosis-specific phosphoproteins  (Vandre et 
al.,  1984); calpain II (Schollmeyer, 1988); a ll2-kD protein 
from grasshopper (Bastmeyer and Russell, 1987); a 205-kD 
thiophosphorylated  protein  in diatoms  (Wordeman  et al., 
1989); and a 225-kD phosphoprotein in sea urchin spindles 
(Kuriyama,  1989).  Additionally,  Mullins  and  Mclntosh 
(1982) observed a ll5-kD doublet on Coomassie stained gels 
of isolated midbodies. CHO1 antigen(s) are, however, unique 
in the localization patterns they display through both inter- 
phase and mitosis. 
The CHO1 antigen is distributed among a subset of spin- 
dle microtubules. During mitosis the CHO1 staining pattern 
changes markedly, shifting from diffuse spindle staining at 
metaphase to an increasingly narrow band of microtubules 
within the interzone during anaphase.  The strong inference 
from the anaphase images is that the CHO1 antigen localizes 
specifically to regions where antiparallel microtubules from 
opposite poles interdigitate. If this is the case throughout mi- 
tosis, our data suggest that during prometaphase and meta- 
phase some microtubules overlap almost all the way to the 
opposite pole. We were unable to test this assertion by im- 
munoelectron microscopy because the CHO1 epitope is ex- 
tremely sensitive to fixation with aldehydes. Several studies 
have,  however, addressed this question.  By reconstructing 
spindles from serial sections prepared for EM (McDonald, 
1989) or by lysing cells with exogenous polarity markers 
(Euteneur et al., 1982; Haimo and Telzer, 1981; Heidemann 
and  Mclntosh,  1980),  microtubules  in prometaphase  and 
metaphase ceils have been shown to extend far into the oppo- 
site half spindle. Although both these methods share several 
potential artifacts, the data suggest that before anaphase, some 
spindle microtubules extend very nearly to the pole opposite 
their site of initiation. 
Our  immunofluorescence observations  show that CHO1 
stains the nuclei of approximately one-fourth to one-third of 
interphase  PtK1 cells.  We have tested to see whether this 
staining was attributable to the same antigen as that seen in 
the spindle by using microtubule-affinity methods on nuclear 
extracts.  Indeed,  it  appears  that  before  nuclear  envelope 
breakdown  the  CHO1  antigen  is  located  in  the  nucleus. 
These observations suggest a scenario whereby CHO1 anti- 
gen is sequestered within the nucleus prior to mitosis (possi- 
bly to prevent its binding to cytoplasmic microtubules); then 
as the nuclear  envelope disperses during  the transition  to 
prometaphase, CHO1 antigen is released into the cytoplasm 
to  participate  in  the  assembly  and/or  stabilization  of the 
spindle. 
Once mitosis is underway, it is clear that the CHO1 antigen 
moves  relative  to  the  surface  of spindle  microtubules.  It 
might therefore be a component of a microtubule-dependent 
motor complex, perhaps involved in anaphase B (Cande et 
al.,  1989).  Unlike  previously  characterized  microtubule- 
based motor molecules, however, the CHO1 antigen is not 
extracted from microtubules with MgATP or MgGTP. This 
property  may result simply from the use of inappropriate 
buffer conditions  or from an  adventitious  blocking of the 
relevant active sites on this antigen by interaction with an- 
other  spindle  component.  In  support of the  latter  idea,  a 
previous  report  demonstrated  that  the  CHO1  antigen  is 
tightly associated with the spindle matrix,  an amorphous, 
electron-dense  material  that  begins  to  appear  within  the 
spindle during metaphase and that becomes concentrated in 
the interzone and midbody during  anaphase and telophase 
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midbodies  with  the  detergent  Sarkosyl  revealed  that  the 
CHO1  staining  persisted,  even after  most of the midbody 
microtubules  had  been  solubilized.  Thus,  in  addition  to 
binding to spindle microtubules, it is likely that the CHO1 
antigen interacts with other, as yet undefined spindle compo- 
nents.  We plan to identify the other proteins that associate 
with the CHO1  antigen(s) in an effort to elucidate the role 
of these proteins in mitosis. 
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